Literature DB >> 13439110

The role of intestinal bacteria in the development of dietary cirrhosis in rats.

A M RUTENBURG, E SONNENBLICK, I KOVEN, H A APRAHAMIAN, L REINER, J FINE.   

Abstract

Diffuse hepatic cirrhosis develops in rats on a choline-deficient diet within 300 days. Absorbable broad spectrum antibiotics added to the daily diet do not prevent the development of fatty infiltration, but they delay the development of cirrhosis for about 100 days more. Non-absorbable antibiotics added to the daily diet prevent the development of cirrhosis in most rats for as long as 750 days. The superiority of non-absorbable antibiotics to absorbable antibiotics excludes a systemic effect of the antibiotics and demonstrates that intestinal bacteria are largely, if not wholly, responsible for the cirrhosis in rats on a choline-deficient diet.

Entities:  

Keywords:  INTESTINES/microbiology; LIVER CIRRHOSIS/experimental

Mesh:

Year:  1957        PMID: 13439110      PMCID: PMC2136738          DOI: 10.1084/jem.106.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Germfree animals and liver necrosis.

Authors:  T D LUCKEY; J A REYNIERS; P GYORGY; M FORBES
Journal:  Ann N Y Acad Sci       Date:  1954-05-10       Impact factor: 5.691

2.  The sequence of pathologic events in the development of experimental fatty liver and cirrhosis.

Authors:  W S HARTROFT
Journal:  Ann N Y Acad Sci       Date:  1954-05-10       Impact factor: 5.691

3.  LABORATORY AND CLINICAL STUDIES OF POLYMYXIN B AND E.

Authors:  E J Pulaski; H J Baker; M L Rosenberg; J F Connell
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

4.  Fatty liver following aureomycin and terramycin therapy in chronic hepatic disease.

Authors:  V M SBOROV; D A SUTHERLAND
Journal:  Gastroenterology       Date:  1951-08       Impact factor: 22.682

5.  Polymyxin B and polymyxin E; clinical and laboratory studies.

Authors:  B M KAGAN; D KREVSKY; A MILZER; M LOCKE
Journal:  J Lab Clin Med       Date:  1951-03

6.  Observation on absorption of bacitracin; blood levels following all administration.

Authors:  A B LONGACRE; R M WATERS
Journal:  Surg Gynecol Obstet       Date:  1951-02

7.  Effect of aureomycin on the growth of weaned pigs.

Authors:  L E CARPENTER
Journal:  Arch Biochem       Date:  1950-07

8.  The polymyxins; a review and assessment.

Authors:  P G STANSLY
Journal:  Am J Med       Date:  1949-12       Impact factor: 4.965

9.  The Occurrence of Neoplasms in the Liver, Lungs, and Other Tissues of Rats as a Result of Prolonged Choline Deficiency.

Authors:  D H Copeland; W D Salmon
Journal:  Am J Pathol       Date:  1946-09       Impact factor: 4.307

10.  Preliminary observations on the effect of aureomycin, terramycin, tibione, combined tibione and streptomycin, and chloromycetin on the morphology of the liver in man.

Authors:  R YESNER; P KUNKEL
Journal:  Yale J Biol Med       Date:  1951-02
  10 in total
  24 in total

1.  THE OCCURRENCE OF LIVER PORTAL CIRRHOSIS AND ATROPHY OF THE ISLET CELLS OF THE PANCREAS IN THE COURSE OF EXPERIMENTAL CANDIDA ALBICANS INFECTION.

Authors:  Z T MANKOWSKI
Journal:  Mycopathol Mycol Appl       Date:  1964-06-30

2.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

Authors:  João-Bruno Soares; Pedro Pimentel-Nunes; Roberto Roncon-Albuquerque; Adelino Leite-Moreira
Journal:  Hepatol Int       Date:  2010-10-21       Impact factor: 6.047

Review 3.  Intestinal endotoxins and macrophages as mediators of liver injury.

Authors:  J P Nolan; D S Camara
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

4.  Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction.

Authors:  Veronica L Massey; Kendall S Stocke; Robin H Schmidt; Min Tan; Nadim Ajami; Rachel E Neal; Joseph F Petrosino; Shirish Barve; Gavin E Arteel
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-08       Impact factor: 4.219

5.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

Review 6.  NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

Authors:  Tom Luedde; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

Review 7.  Advances in alcoholic liver disease.

Authors:  Juliane I Beier; Gavin E Arteel; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2011-02

Review 8.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04

9.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

Review 10.  Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?

Authors:  Michele T Pritchard; Jennifer M McCracken
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.